Answer
Prevenar 13 is indicated for active immunisation against invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents aged 6 weeks to 17 years.
Sources for this answer
- Prevenar 13 suspension for injectionPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 33Document updated
Sources checked